Use este identificador para citar o ir al link de este elemento: http://hdl.handle.net/1843/54960
Tipo: Artigo de Periódico
Título: Mycobacterial hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients
Autor(es): Pryscilla Fanini Wowk
Flávia Dias Coelho Silva
Solange Alves Vinhas
Olindo Assis Martins Filho
Moisés Palaci
Célio Lopes Silva
Vânia Luiza Deperon Bonato
Luís Henrique Franco
Denise Morais da Fonseca
Marina Oliveira Paula
Élcio Dos Santos Oliveira Vianna
Ana Paula Barbosa Wedling
Valéria Maria Augusto
Silvana Maria Elói Santos
Andréa Teixeira Carvalho
Resumen: Previously we showed that 65-kDa Mycobacterium leprae heat shock protein (Hsp65) is a target for the development of a tuberculosis vaccine. Here we evaluated peripheral blood mononuclear cells (PBMC) from healthy individuals or tuberculosis patients stimulated with two forms of Hsp65 antigen, recombinant DNA that encodes Hsp65 (DNA-HSP65) or recombinant Hsp65 protein (rHsp65) in attempting to mimic a prophylactic or therapeutic study in vitro, respectively. Proliferation and cytokine-producing CD4C or CD8C cell were assessed by flow cytometry. The CD4C cell proliferation from healthy individuals was stimulated by DNA-HSP65 and rHsp65, while CD8C cell proliferation from healthy individuals or tuberculosis patients was stimulated by rHSP65. DNA-HSP65 did not improve the frequency of IFN gammaC cells from healthy individuals or tuberculosis patients. Furthermore, we found an increase in the frequency of IL-10-producing cells in both groups. These findings show that Hsp65 antigen activates human lymphocytes and plays an immune regulatory role that should be addressed as an additional antigen for the development of antigen-combined therapies.
Asunto: Interferon beta
Interleucina-10
Tuberculose
Vaccinia
Idioma: eng
País: Brasil
Editor: Universidade Federal de Minas Gerais
Sigla da Institución: UFMG
Departamento: ICB - DEPARTAMENTO DE BIOQUÍMICA E IMUNOLOGIA
MED - DEPARTAMENTO DE CLÍNICA MÉDICA
Tipo de acceso: Acesso Aberto
Identificador DOI: 10.1080/21645515.2016.1264547
URI: http://hdl.handle.net/1843/54960
Fecha del documento: 21-feb-2017
metadata.dc.url.externa: https://www.tandfonline.com/doi/full/10.1080/21645515.2016.1264547
metadata.dc.relation.ispartof: Human Vaccines & Immunotherapeutics
Aparece en las colecciones:Artigo de Periódico



Los elementos en el repositorio están protegidos por copyright, con todos los derechos reservados, salvo cuando es indicado lo contrario.